MR-Guided High-Intensity Focused Ultrasound Ablation of Breast Cancer with a Dedicated Breast Platform
- 1.1k Downloads
Optimizing the treatment of breast cancer remains a major topic of interest. In current clinical practice, breast-conserving therapy is the standard of care for patients with localized breast cancer. Technological developments have fueled interest in less invasive breast cancer treatment. Magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) is a completely noninvasive ablation technique. Focused beams of ultrasound are used for ablation of the target lesion without disrupting the skin and subcutaneous tissues in the beam path. MRI is an excellent imaging method for tumor targeting, treatment monitoring, and evaluation of treatment results. The combination of HIFU and MR imaging offers an opportunity for image-guided ablation of breast cancer. Previous studies of MR-HIFU in breast cancer patients reported a limited efficacy, which hampered the clinical translation of this technique. These prior studies were performed without an MR-HIFU system specifically developed for breast cancer treatment. In this article, a novel and dedicated MR-HIFU breast platform is presented. This system has been designed for safe and effective MR-HIFU ablation of breast cancer. Furthermore, both clinical and technical challenges are discussed, which have to be solved before MR-HIFU ablation of breast cancer can be implemented in routine clinical practice.
KeywordsBreast Interventional oncology High-intensity focused ultrasound Cancer
This research was supported by the Center for Translational Molecular Medicine (VOLTA, Work Package 3).
Conflict of interest
This research was performed in collaboration with Philips Healthcare. Max O. Köhler is currently employed in this company. The other authors declare that they have no conflict of interest.
- 4.van Dongen JA, Bartelink H, Fentiman IS et al (1992) Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 28A(4–5):801–805PubMedCrossRefGoogle Scholar
- 53.Moonen CT, Mougenot C (2006) MRI-guided focused ultrasound, apparatus for novel treatment of breast cancer, vol 6. Springer, Philips Research Book Series, New York, pp 183–200Google Scholar
- 55.Mougenot C, Köhler M, Tillander M, Moonen C, Bartels W, Ehnholm GJ (2011) Large aperture transducer designed for MR-HIFU treatment of breast tumors. Paper presented at the ISMRM 2011 in the session Interventional MRI: MR-Guided Focused UltrasoundGoogle Scholar